This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
Integrating Metabolism and Immunity - VIRTUAL CONTENT AVAILABLE ON DEMAND
Organizer(s): Marc Y. Donath, Tom Thuren, Bruce M. Spiegelman and Diane Mathis
Date: January 25 - 28, 2021
Location: Virtual at your computer. Recorded presentation content is available On Demand.
Sponsored by AbbVie Inc., Astellas Pharma Inc., Cell Research, Merck & Co., Inc. and Novo Nordisk A/S
For important information on the coronavirus, please click here
Summary of Meeting:
Traditionally, metabolism and immunity have been perceived as two distinct systems with distinct functions: metabolism regulates the disposal and transformation of nutrients, whereas the immune system is responsible for host defense. However, in a broader sense, these two processes are both an organism’s response to stressors, with the aim of restoring homeostasis. An increasing amount of evidence has demonstrated that the chronic activation of the immune system associated with overnutrition may be deleterious, contributing importantly to diabetes and long-term complications, such as cardiovascular disorders. Such dysregulation of the immune system may reflect the duration and magnitude of the metabolic stress, along with genetic predispositions. Accordingly, anti-inflammatory treatments of metabolic diseases emerge as therapies interfering with the pathogenesis of these illnesses and offer disease-modifying potential. Therefore, it is critical that clinical translation be based on an understanding of the physiology and pathophysiology of the role of the immune system in metabolism. This conference will bring together basic scientists and clinicians from both disciplines in order to spark innovative ways of understanding the interactions between the immune system and metabolism. The conference organizers anticipate that the conference will lead to the development of novel therapeutic concepts based on the pathways underlying the pathogenesis of diseases rather than on the manifestation of symptoms belonging to a specific clinical discipline.
Scholarship Deadline: November 1 2020
Abstract Deadline: December 16 2020
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
AbbVie Inc.Astellas Pharma Inc.Cell ResearchMerck & Co., Inc.Novo Nordisk A/S
We gratefully acknowledge additional support for this conference from:
AdipoGen Life SciencesSable Systems International
We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Grant No. 1 R13 DK125009-01
Funding for this conference was made possible (in part) by 1 R13 DK125009-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found